Serum beta 2-microglobulin at HIV-1 seroconversion as a predictor of severe immunodeficiency during 10 years of followup

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):262-6. doi: 10.1097/00042560-199611010-00008.

Abstract

In order to examine the relevance of early immune activation to the long-term course of HIV infection, we evaluated the ability of the serum beta 2-microglobulin level measured in 63 haemophiliacs on average 4.9 months from HIV seroconversion to predict the rate of development of server immunodeficiency (CD4) lymphocyte count 50/mm3) or AIDS over the following 10 years. Patients with higher beta 2-microglobulin values tended to develop severe immunodeficiency/AIDS more rapidly than those with lower levels (relative risk 1.68 per 1 mg/L increase; 95% CI 1.26-2.26; p = 0.0004). Older patients also progressed more rapidly, and these two factors acted independently (relative risk 1.65 per 1 mg/L increase; 95% CI 1.21-2.72; p = 0.002 for beta 2-microglobulin and 1.22 per 10 years; 95% CI 1.01-1.48; p = 0.04 for age). These results provide further evidence that the long-term course of HIV infection can, to some extent, be predicted soon after infection. Older patients with high beta 2-microglobulin levels warrant close monitoring and consideration for early antiretroviral therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Biomarkers
  • CD4 Lymphocyte Count
  • Child
  • Child, Preschool
  • Disease Progression
  • Follow-Up Studies
  • HIV Infections / blood
  • HIV Infections / immunology*
  • HIV Infections / metabolism*
  • HIV Seropositivity / metabolism*
  • HIV-1*
  • Hemophilia A / complications*
  • Hemophilia A / immunology
  • Hemophilia A / metabolism
  • Hemophilia A / virology*
  • Humans
  • Male
  • Middle Aged
  • Severity of Illness Index
  • beta 2-Microglobulin / analysis*

Substances

  • Biomarkers
  • beta 2-Microglobulin